Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
Titel:
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy
Auteur:
Magbanua, Mark Jesus M. Brown Swigart, Lamorna Ahmed, Ziad Sayaman, Rosalyn W. Renner, Derrick Kalashnikova, Ekaterina Hirst, Gillian L. Yau, Christina Wolf, Denise M. Li, Wen Delson, Amy L. Asare, Smita Liu, Minetta C. Albain, Kathy Chien, A. Jo Forero-Torres, Andres Isaacs, Claudine Nanda, Rita Tripathy, Debu Rodriguez, Angel Sethi, Himanshu Aleshin, Alexey Rabinowitz, Matthew Perlmutter, Jane Symmans, W. Fraser Yee, Douglas Hylton, Nola M. Esserman, Laura J. DeMichele, Angela M. Rugo, Hope S. van ’t Veer, Laura J.